GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 634 filers reported holding GLAXOSMITHKLINE PLC in Q2 2013. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $429,000 | -15.6% | 10,570 | -16.1% | 0.04% | -20.0% |
| Q4 2015 | $508,000 | -73.7% | 12,600 | -75.0% | 0.06% | -71.8% |
| Q3 2015 | $1,935,000 | -9.8% | 50,325 | -2.3% | 0.20% | -2.0% |
| Q2 2015 | $2,146,000 | -83.9% | 51,520 | -82.2% | 0.20% | -79.5% |
| Q1 2015 | $13,350,000 | +31.8% | 289,265 | +22.1% | 0.97% | +29.2% |
| Q4 2014 | $10,127,000 | +30.0% | 236,950 | +39.8% | 0.75% | +32.8% |
| Q3 2014 | $7,791,000 | -9.6% | 169,470 | +5.2% | 0.57% | -8.4% |
| Q2 2014 | $8,615,000 | -18.7% | 161,085 | -18.8% | 0.62% | -22.2% |
| Q1 2014 | $10,599,000 | -3.1% | 198,370 | -3.1% | 0.80% | -8.6% |
| Q4 2013 | $10,933,000 | +5.4% | 204,785 | -0.9% | 0.87% | -0.5% |
| Q3 2013 | $10,368,000 | +25.2% | 206,660 | +24.7% | 0.88% | +15.4% |
| Q2 2013 | $8,281,000 | – | 165,715 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |